Cosentino, Marco <br/><br/>
Dopaminergic modulation of CD4+CD25(high) regulatory T lymphocytes in multiple sclerosis patients during interferon-β therapy.  [electronic resource] 

 -  Neuroimmunomodulation  2012 
 - 283-92 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1423-0216 
<br/><br/><label>Standard No.: </label>10.1159/000336981  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Analysis of Variance<br/>CD4 Antigens--metabolism<br/>Cell Proliferation--drug effects<br/>Disability Evaluation<br/>Dopamine--pharmacology<br/>Female<br/>Forkhead Transcription Factors--genetics<br/>Gene Expression Regulation--drug effects<br/>Humans<br/>Immunologic Factors--therapeutic use<br/>Interferon-beta--therapeutic use<br/>Interleukin-2 Receptor alpha Subunit--metabolism<br/>Male<br/>Middle Aged<br/>Multiple Sclerosis, Relapsing-Remitting--drug therapy<br/>Phytohemagglutinins<br/>RNA, Messenger<br/>Receptors, Dopamine D3--genetics<br/>Receptors, Dopamine D5--genetics<br/>Severity of Illness Index<br/>Statistics, Nonparametric<br/>T-Lymphocytes, Regulatory--drug effects<br/>Tyrosine 3-Monooxygenase--genetics